Cargando…
Hepatocellular Carcinoma: Novel Molecular Targets in Carcinogenesis for Future Therapies
BACKGROUND: Hepatocellular carcinoma is one of the most common and lethal malignant tumors worldwide. Over the past 15 years, the incidence of HCC has more than doubled. Due to late diagnosis and/or advanced underlying liver cirrhosis, only limited treatment options with marginal clinical benefit ar...
Autores principales: | Bertino, Gaetano, Demma, Shirin, Ardiri, Annalisa, Proiti, Maria, Malaguarnera, Giulia, Bertino, Nicoletta, Malaguarnera, Michele, Malaguarnera, Mariano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4096380/ https://www.ncbi.nlm.nih.gov/pubmed/25089265 http://dx.doi.org/10.1155/2014/203693 |
Ejemplares similares
-
The Immune System in Hepatocellular Carcinoma and Potential New Immunotherapeutic Strategies
por: Bertino, Gaetano, et al.
Publicado: (2015) -
Rare Benign Tumors of the Liver: Still Rare?
por: Bertino, Gaetano, et al.
Publicado: (2014) -
Responsibility of hepatitis C virus in the development of hepatocellular carcinoma: From molecular alterations to possible solutions
por: Bertino, Gaetano, et al.
Publicado: (2018) -
Serum Folate deficiency in HCV related Hepatocellular Carcinoma
por: Malaguarnera, Giulia, et al.
Publicado: (2022) -
Folate levels in hepatocellular carcinoma patients with portal vein thrombosis
por: Malaguarnera, Giulia, et al.
Publicado: (2020)